Short and mid-term outcomes of multimodal treatment for locally-advanced non-small cell lung cancer in elderly patients

  • PDF / 696,211 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 12 Downloads / 203 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

Short and mid‑term outcomes of multimodal treatment for locally‑advanced non‑small cell lung cancer in elderly patients Stefano Bongiolatti1 · Francesca Mazzoni2 · Alessandro Gonfiotti1 · Giulia Di Pierro2 · Alberto Salvicchi1   · Sara Borgianni1 · Katia Ferrari3 · Luca Voltolini1 Received: 18 January 2020 / Accepted: 5 May 2020 © The Japanese Association for Thoracic Surgery 2020

Abstract Objective  Multimodality treatments are effective for locally advanced non-small cell lung cancer (LA-NSCLC) showing benefits in overall (OS) and disease-free survival (DFS), but these options are frequently denied to elderly patients. Methods  The objectives of this retrospective study were: to investigate mortality, morbidity and oncological outcomes of pulmonary resection after induction therapy (IT) for NSCLC in elderly patients. We divided the cohort into two: patients